JN BIOTECH ApS: Financial statements 2024
CVR: 25325001
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
JN BIOTECH ApS (CVR 25325001) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 28,021 and a net result of DKK 60,995 compared with DKK 150,483 the year before. That is a decrease of 75.6% compared with the year before. Equity in the 2024 report amounted to DKK 716,753. The solvency ratio was 55.4%.
- Gross Profit
- DKK 28,021
- Profit/Loss
- DKK 60,995
- Equity
- DKK 716,753
- Total Assets
- DKK 1,293,331
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 28K | 61K | 717K | 0 |
| 2023 | - | 115K | 150K | 656K | 0 |
| 2022 | - | 82K | 338K | 3M | 0 |
| 2021 | - | 116K | 1.6M | 15.7M | 0 |
| 2018 | - | 73K | 12.8M | 13.7M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout JN BIOTECH ApS
JN BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Andre personlige serviceydelser i.a.n.. The management consists of Jens Bredal Nielsen. The company is owned by JBN Biotech ApS. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK 90,325 and a net result of DKK 104,408 compared with DKK 60,995 the year before. Equity in the 2025 report amounted to DKK 821,161.